Slowinska-Klencka Dorota, Sporny Stanislaw, Stasikowska-Kanicka Olga, Popowicz Bozena, Klencki Mariusz
Department of Morphometry of Endocrine Glands, Chair of Endocrinology, Medical University of Lodz, Poland.
Folia Histochem Cytobiol. 2012;50(4):519-26. doi: 10.5603/20322.
The aim of this study was to evaluate the relationship between abnormal expression of E-cadherin (E-CAD) and the extracapsular extension of tumors, lymph node involvement and the presence of metastasis in various types of thyroid cancers. Histopathological specimens of 35 benign thyroid lesions and 122 malignant tumors (papillary, follicular, poorly differentiated and undifferentiated cancers) were analyzed. E-CAD immunostaining intensity, its subcellular localization, homogeneity within lesion, and the relation of staining intensity between tumor and surrounding thyroid parenchyma were evaluated. The obtained results show that the variants of differentiated cancers with a poorer prognosis (i.e. tall cell and follicular variants of papillary cancer and widely invasive follicular cancers) present reduced intensity of E-CAD expression, its abnormal localization or heterogeneity of staining more frequently than classical papillary cancers and minimally invasive follicular cancers. However, the assessment of E-CAD expression does not allow the prediction of extrathyroidal growth of thyroid cancers.
本研究的目的是评估E-钙黏蛋白(E-CAD)异常表达与各类甲状腺癌肿瘤包膜外扩展、淋巴结受累及转移情况之间的关系。分析了35例甲状腺良性病变及122例恶性肿瘤(乳头状癌、滤泡状癌、低分化癌和未分化癌)的组织病理学标本。评估了E-CAD免疫染色强度、其亚细胞定位、病变内的同质性以及肿瘤与周围甲状腺实质之间的染色强度关系。所得结果表明,预后较差的分化型癌变体(即乳头状癌的高细胞和滤泡状变体以及广泛侵袭性滤泡状癌)比经典乳头状癌和微侵袭性滤泡状癌更频繁地出现E-CAD表达强度降低、其定位异常或染色异质性。然而,对E-CAD表达的评估并不能预测甲状腺癌的甲状腺外生长情况。